Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $57.3920 (1.9%) ($56.1128 - $57.5451) on Mon. May. 9, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.4% (three month average) | RSI | 79 | Latest Price | $57.3920(1.9%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV advances 0.7% a day on average for past five trading days. | Weekly Trend | ABBV advances 1.3% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(62%) VYM(49%) IVE(47%) SPY(47%) IWD(46%) | Factors Impacting ABBV price | ABBV will decline at least -0.7% in a week (0% probabilities). VIXM(-19%) TLT(-14%) UUP(-10%) IGOV(-3%) IPO(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.7% (StdDev 1.4%) | Hourly BBV | 0 () | Intraday Trend | 2.1% | | | |
|
5 Day Moving Average | $56.18(2.16%) | 10 Day Moving Average | $55.64(3.15%) | 20 Day Moving Average | $54.95(4.44%) | To recent high | 0% | To recent low | 23.3% | Market Cap | $101.256b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |